Exclusive Working Luncheons: Where Policy Meets Action
At EHS, the conversation does not stop at the main stage - it continues in exclusive working luncheons, where decision-makers, industry leaders, and experts engage in unfiltered, solution-driven discussions on Europe’s most pressing health challenges.
These invite-only sessions provide a rare opportunity for a direct exchange of ideas that can bring to practical solutions of the future of European healthcare beyond the main Summit stage.
These exclusive, interactive sessions - held under the Chatham House Rule - provide an unparalleled opportunity to influence key policy discussions and drive tangible outcomes that will shape the future of healthcare in Europe.
THE FIRST 100 DAYS LUNCHEON
A behind-closed-doors session with key EU policymakers, focusing on the priorities for the first 100 days of the new legislative cycle. What policies will shape the next five years of European healthcare? How can industry and institutions collaborate to drive meaningful change?
HEALTH MEETS DIGITAL LUNCHEON
A deep dive into the digital transformation of healthcare, featuring cutting-edge discussions on AI-driven diagnostics, the European Health Data Space, and regulatory frameworks needed to accelerate innovation while protecting patients.
EUROPE’S INDUSTRIAL SOVEREIGNTY & HEALTHCARE LUNCHEON
As Europe pushes for greater autonomy in its healthcare supply chains, this session explores how to strengthen manufacturing, reduce dependencies on non-EU suppliers, and drive strategic investments in biotech, pharma, and medtech.
SUSTAINABILITY & HEALTH LUNCHEON
The growing intersection between environmental sustainability and healthcare takes center stage. How can the healthcare sector reduce its carbon footprint, adopt circular economy principles, and align with the EU’s Green Deal while ensuring equitable access to care?
THE FUTURE OF BIOTECHNOLOGY IN EUROPE LUNCHEON
Biotech is transforming healthcare, but can Europe lead the way? This session brings together biotech pioneers, regulators, and investors to discuss the EU’s biotech strategy, investment landscape, and policy enablers for global competitiveness.
Quantum Computing & Healthcare Luncheon
Quantum technology is set to revolutionize healthcare—but is Europe ready? This forward-looking discussion explores the potential of quantum computing in diagnostics, drug discovery, and personalized medicine, as well as the ethical and regulatory challenges ahead.
Biotechnology & Life Sciences Working Stream: A Roadmap for Europe’s Biotech Future
Biotechnology is the cornerstone of Europe’s health, industrial, and economic future. Recognising this, EHS has launched the Biotechnology & Life Sciences Working Stream, a dynamic, multi-city, and multi-stakeholder initiative dedicated to ensuring that biotech innovation is firmly integrated into Europe’s industrial, societal, healthcare, and economic strategies.
Our efforts began at EHS 2024, where a landmark panel discussion and expert roundtable brought together leading voices in biotech, investment, and policy. A clear consensus emerged: Europe must move from discussion to measurable action - leveraging its scientific excellence, regulatory strengths, and industrial capabilities while addressing the structural barriers holding back biotech’s full potential.
This initiative is more than just discussions - it’s about driving concrete action, shaping policy, and accelerating investment in biotech and life sciences. From strategic roundtables with policymakers to high-impact summits, industry workshops, and cross- border collaborations, we are ensuring that biotech remains at the forefront of Europe’s healthcare transformation.
This initiative is more than just discussions - it’s about driving concrete action, shaping policy, and accelerating investment in biotech and life sciences. From strategic roundtables with policymakers to high-impact summits, industry workshops, and cross- border collaborations, we are ensuring that biotech remains at the forefront of Europe’s healthcare transformation.
Want to dive deeper? Access our in-depth policy recommendations and strategic roadmap to see how EHS is actively shaping the future of biotech in Europe. Download the Full Report
DO YOU WANT TO KNOW MORE?
